RE:RE:RE:Should a comparison be made between Bioasis and Denali?hummm,,, a couple of things to note here;
1) Denalis revenue is about $25 million,,they are ahead of us time wise but not overly paced where we will never catch them,,or will we ever have to!
2) They are being priced at a lofty valuation for signed deals and intial results. Nothing says any of it gets to market.
3) When BTI was asked where our share price mught be in three years the answer was,,,the sky is the limit!,,
4)Our science seems to be superior. We might get an announcemnet around human trials at anytime by one of our partners!
5) Denali ($93 today) was formed in 2015,,IPO was initiated in 2017. which raised $250 Million.
The take from it,,,,no massive reward comes unless massive risk is absorbed,,,if the kithchen gets too hot one must decide to take the appropriate action and get out,,hint,,hint!